Pharmacy

In the first full quarter since its launch in May 2019, Novartis' $2.1 million gene therapy Zolgensma has beat analyst's sales expectations, according to STAT. 

Consumers have sued several Zantac manufacturers for allegedly failing to disclose that the heartburn drug can produce small amounts of a possible carcinogen, according to STAT.

The FDA approved a treatment that can treat the majority of cystic fibrosis patients.

One in eight pharmacies in the U.S. closed between 2009 and 2015, and the majority were independent pharmacies located in low-income neighborhoods, according to a study published Oct. 21 in JAMA Internal Medicine.

Medical device and drug recalls, whether voluntary or forced by the FDA, ensure patient safety. Here are six reported by Becker's Hospital Review in the last month:

Here are 10 hospitals and health systems that posted job listings seeking pharmacy leaders in the last week.

The FDA approved a drug to treat patients with a high risk of developing complications from the flu.

Novant Health's Oct. 1 announcement that it will open retail health clinics in several Walgreens pharmacies in North Carolina comes amid a stream of retailers taking on healthcare.

Sanofi is recalling Zantac in the U.S. a month after the FDA warned the heartburn drug contained a possible carcinogen.

A former CSL Behring senior medical affairs director allegedly stole more than 21,000 files containing valuable trade secrets before he left the company for a job at Pharming, a competing drugmaker, according to STAT.